CGRP Forum

1/10 children & teens experience #migraine, yet only one anti-CGRP therapy is approved for them. A small study of off-label #rimegepant in under-18s shows promising pain relief—but needs clinical trial confirmation. Read more: cgrpforum.org/rimegepant-imp… @ihs_official @NatMigraineCtr

The American Headache Society has proposed annual #migraine screening for women as part of their preventive healthcare services. Annual screening is simple, scalable, and evidence based. Read more on @cgrpforum >> cgrpforum.org/ahs-proposes-a… @ahsheadache #headache

Drs Reem Suliman and Dr Taoufik Alsaadi, from the The American Center for Psychiatry and Neurology, Abu Dhabi, UAE, discuss their recent research showing the effects of using #gepants to bridge the gap in #migraine prevention. Read more on #CGRP Forum >> cgrpforum.org/bridging-cgrp-…

Real-world data support adding #antiCGRP therapy to #onabotulinumtoxinA for chronic #migraine, with meaningful reductions in migraine frequency, acute medication use, and disability. Read more on #CGRP Forum >> cgrpforum.org/synergy-real-w… #NeuroTwitter #MigraineTwitter @Lanfpelledoc

More physicians are combining anti-CGRP therapies with #onabotulinumtoxinA for hard-to-treat #migraine. What’s the evidence—and what should patients and doctors discuss first? Read our new Hot Topic on @cgrpforum by Dr Lanfranco Pellesi: cgrpforum.org/combining-onab… @Lanfpelledoc

#Migraine treatments targeting #CGRP or its receptor are now widely available. Explore recent approvals and global indications in our expert guide to the regulatory status of anti-CGRP therapies >> cgrpforum.org/is-anti-cgrp-t… #neurologists #GPs #pharmacists

If you don’t want to trawl through all the recent literature about #CGRP science and studies of anti-CGRP therapies for #migraine, look no further than @cgrpforum for summaries of key studies that could affect your clinical practice > cgrpforum.org/resources/cgrp… #neurologists #nurses

New real-world data from Canada (73k+ people): ~1 in 10 with #migraine switch anti-#CGRP therapies in their first year. See what most did—and the impact—on @cgrpforum >> cgrpforum.org/us-prescriptio… #switchingCGRPinhibitors @McGillUniversit #neurologists #GPs #pharmacists #nurses

New data on CGRP Forum: ~1 in 5 people with #migraine who stop #CGRP mAbs at 6 months for #reimbursement reasons still benefit—and would meet criteria if treated for 12 months. Read more: cgrpforum.org/false-non-resp… #neurologists #GPs #pharmacists #nurses @UniBarcelona

What a year for #migraine science and CGRP-targeted care! @cgrpforum has helped bring the latest #CGRP science and clinical experience to #clinicians and #scientists worldwide. Take a look on >> cgrpforum.org #headache #neurology @ihs_official @EANeurology @AANmember

How does your experience of long term use of #CGRPmAbs compare with other #migraine treatment centres? Take a look at real world data from a major UK #headache centre, presented at #EHC25, and summarised on @cgrpforum >> cgrpforum.org/cgrp-mab-exper… @KingsCollegeLon #neuroTwitter

Questions remain about #CGRPmAbs in #pregnancy. New data from Norway’s national birth registry, presented at #EHC25 offer early insights for clinicians and patients >> cgrpforum.org/norwegian-regi… #CGRP #migraine #neurologists #GPs #pharmacists #nurses @NorHeadResearch @EHF_Official

Can #clinicians combine anti-CGRP therapies to both prevent and treat #migraine without changing their efficacy and safety? Check out the results of the UNION trial presented at #EHC25 and reported on @cgrpforum >> cgrpforum.org/union-study-co… #CGRPmAbs #combinationTherapy #headache

Patients with #migraine who don’t respond to a #CGRP monoclonal antibody are often switched to another antibody or to a #gepant, but which should clinicians choose? Read latest insights on @cgrpforum >> cgrpforum.org/should-patient… #EHC25 #neurologists #GPs #pharmacists #nurses

What is a #migraine day? An analysis of 23 trials found 12 different definitions. International specialists have proposed standardised definitions across 3 clinical scenarios. Read more in our reports from #EHC2025 on @cgrpforum >> cgrpforum.org/redefining-a-m… #CGRP @petergoadsby

Take a look at the first data from the ECLIPSE trial on acute migraine treatment with the anti-CGRP therapy, atogepant, reported on @cgrpforum after #EHC2025 >> cgrpforum.org/eclipse-data-s… #CGRP #migraine #atogepant @EHF_Official

Missed #EHC2025? Catch key updates on @cgrpforum: ECLIPSE #atogepant data, UNION #ubrogepant + #CGRP mAb results, new #migraine-day definition, treatment-switching insights, real-world data, and pregnancy registry findings. cgrpforum.org/articles/meeti… @EHF_Official @MigraineTrust

If your patients are finding it hard to access anti-CGRP therapies, take a look at our report on #CGRP Forum about a new position paper from the AMF outlining key barriers and potential solutions >> cgrpforum.org/breaking-down-… @amfmigraine #migraine #accesstotreatment #neurologists

Can you predict #migraine patients that will be super- or absolute responders to #CGRPmAbs? New real world data from #ItalianMigraineRegistry shows that it can take at least 6 months to see 75% or 100% responders to treatment > cgrpforum.org/best-responder… #neurologists #pharmacists

Which patients with #migraine respond best to #antiCGRP mAbs and how satisfied are patients with resistant migraine when using these agents? Read more on questions addressed in recent medical publications > cgrpforum.org/resources/cgrp… #neurologists #GPs #pharmacists #medicaljournals